Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 32630719)

  • 1. Combined Treatment of Heteronemin and Tetrac Induces Antiproliferation in Oral Cancer Cells.
    Huang CH; Huang TY; Chang WJ; Pan YS; Chu HR; Li ZL; Unson S; Chin YT; Lin CY; Huang HM; Hsiung CN; Gionfra F; De Vito P; Pedersen JZ; Incerpi S; Chen YR; Lee SY; Lin HY; Davis PJ; Whang-Peng J; Wang K
    Mar Drugs; 2020 Jul; 18(7):. PubMed ID: 32630719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heteronemin and tetrac derivatives suppress non-small cell lung cancer growth via ERK1/2 inhibition.
    Chung CC; Huang TY; Chu HR; De Luca R; Candelotti E; Huang CH; Yang YSH; Incerpi S; Pedersen JZ; Lin CY; Huang HM; Lee SY; Li ZL; ChangOu CA; Li WS; Davis PJ; Lin HY; Whang-Peng J; Wang K
    Food Chem Toxicol; 2022 Mar; 161():112850. PubMed ID: 35151786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heteronemin and Tetrac Induce Anti-Proliferation by Blocking EGFR-Mediated Signaling in Colorectal Cancer Cells.
    Unson S; Chang TC; Yang YN; Wang SH; Huang CH; Crawford DR; Huang HM; Li ZL; Lin HY; Whang-Peng J; Wang K; Davis PJ; Li WS
    Mar Drugs; 2022 Jul; 20(8):. PubMed ID: 36005485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The combination of tetraiodothyroacetic acid and cetuximab inhibits cell proliferation in colorectal cancers with different K-ras status.
    Lee YS; Chin YT; Yang YSH; Wei PL; Wu HC; Shih A; Lu YT; Pedersen JZ; Incerpi S; Liu LF; Lin HY; Davis PJ
    Steroids; 2016 Jul; 111():63-70. PubMed ID: 26980146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The power of heteronemin in cancers.
    Wang K; Chen YF; Yang YSH; Huang HM; Lee SY; Shih YJ; Li ZL; Whang-Peng J; Lin HY; Davis PJ
    J Biomed Sci; 2022 Jun; 29(1):41. PubMed ID: 35705962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heteronemin Is a Novel c-Met/STAT3 Inhibitor Against Advanced Prostate Cancer Cells.
    Wu JC; Wang CT; Hung HC; Wu WJ; Wu DC; Chang MC; Sung PJ; Chou YW; Wen ZH; Tai MH
    Prostate; 2016 Dec; 76(16):1469-1483. PubMed ID: 27416770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel function of the thyroid hormone analog tetraiodothyroacetic acid: a cancer chemosensitizing and anti-cancer agent.
    Rebbaa A; Chu F; Davis FB; Davis PJ; Mousa SA
    Angiogenesis; 2008; 11(3):269-76. PubMed ID: 18386142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heteronemin Induces Anti-Proliferation in Cholangiocarcinoma Cells via Inhibiting TGF-β Pathway.
    Lin HY; Tey SL; Ho Y; Chin YT; Wang K; Whang-Peng J; Shih YJ; Chen YR; Yang YN; Chen YC; Liu YC; Tang HY; Yang YS
    Mar Drugs; 2018 Dec; 16(12):. PubMed ID: 30563284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamic modeling of anti-cancer activity of tetraiodothyroacetic acid in a perfused cell culture system.
    Lin HY; Landersdorfer CB; London D; Meng R; Lim CU; Lin C; Lin S; Tang HY; Brown D; Van Scoy B; Kulawy R; Queimado L; Drusano GL; Louie A; Davis FB; Mousa SA; Davis PJ
    PLoS Comput Biol; 2011 Feb; 7(2):e1001073. PubMed ID: 21304935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tetrac downregulates β-catenin and HMGA2 to promote the effect of resveratrol in colon cancer.
    Nana AW; Chin YT; Lin CY; Ho Y; Bennett JA; Shih YJ; Chen YR; Changou CA; Pedersen JZ; Incerpi S; Liu LF; Whang-Peng J; Fu E; Li WS; Mousa SA; Lin HY; Davis PJ
    Endocr Relat Cancer; 2018 Mar; 25(3):279-293. PubMed ID: 29255096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response of human pancreatic cancer cell xenografts to tetraiodothyroacetic acid nanoparticles.
    Yalcin M; Lin HY; Sudha T; Bharali DJ; Meng R; Tang HY; Davis FB; Stain SC; Davis PJ; Mousa SA
    Horm Cancer; 2013 Jun; 4(3):176-85. PubMed ID: 23456390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tetraiodothyroacetic acid and tetraiodothyroacetic acid nanoparticle effectively inhibit the growth of human follicular thyroid cell carcinoma.
    Yalcin M; Bharali DJ; Dyskin E; Dier E; Lansing L; Mousa SS; Davis FB; Davis PJ; Mousa SA
    Thyroid; 2010 Mar; 20(3):281-6. PubMed ID: 20187783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heteronemin, a Spongean Sesterterpene, Induces Cell Apoptosis and Autophagy in Human Renal Carcinoma Cells.
    Wu SY; Sung PJ; Chang YL; Pan SL; Teng CM
    Biomed Res Int; 2015; 2015():738241. PubMed ID: 26090440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Marine Terpenoid, Heteronemin, Induces Both the Apoptosis and Ferroptosis of Hepatocellular Carcinoma Cells and Involves the ROS and MAPK Pathways.
    Chang WT; Bow YD; Fu PJ; Li CY; Wu CY; Chang YH; Teng YN; Li RN; Lu MC; Liu YC; Chiu CC
    Oxid Med Cell Longev; 2021; 2021():7689045. PubMed ID: 33488943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modification of survival pathway gene expression in human breast cancer cells by tetraiodothyroacetic acid (tetrac).
    Glinskii AB; Glinsky GV; Lin HY; Tang HY; Sun M; Davis FB; Luidens MK; Mousa SA; Hercbergs AH; Davis PJ
    Cell Cycle; 2009 Nov; 8(21):3562-70. PubMed ID: 19838061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tetraiodothyroacetic acid and its nanoformulation inhibit thyroid hormone stimulation of non-small cell lung cancer cells in vitro and its growth in xenografts.
    Mousa SA; Yalcin M; Bharali DJ; Meng R; Tang HY; Lin HY; Davis FB; Davis PJ
    Lung Cancer; 2012 Apr; 76(1):39-45. PubMed ID: 22024450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NDAT suppresses pro-inflammatory gene expression to enhance resveratrol-induced anti-proliferation in oral cancer cells.
    Ho Y; Wu CY; Chin YT; Li ZL; Pan YS; Huang TY; Su PY; Lee SY; Crawford DR; Su KW; Chiu HC; Shih YJ; Changou CA; Yang YSH; Whang-Peng J; Chen YR; Lin HY; Mousa SA; Davis PJ; Wang K
    Food Chem Toxicol; 2020 Feb; 136():111092. PubMed ID: 31883986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heteronemin, a Marine Sesterterpenoid-Type Metabolite, Induces Apoptosis in Prostate LNcap Cells via Oxidative and ER Stress Combined with the Inhibition of Topoisomerase II and Hsp90.
    Lee MG; Liu YC; Lee YL; El-Shazly M; Lai KH; Shih SP; Ke SC; Hong MC; Du YC; Yang JC; Sung PJ; Wen ZH; Lu MC
    Mar Drugs; 2018 Jun; 16(6):. PubMed ID: 29890785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Estrogen on Heteronemin-Induced Anti-proliferative Effect in Breast Cancer Cells With Different Estrogen Receptor Status.
    Yang YSH; Li ZL; Huang TY; Su KW; Lin CY; Huang CH; Chen HY; Lu MC; Huang HM; Lee SY; Whang-Peng J; Lin HY; Davis PJ; Wang K
    Front Cell Dev Biol; 2021; 9():688607. PubMed ID: 34381775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tetraiodothyroacetic acid (tetrac) and nanoparticulate tetrac arrest growth of medullary carcinoma of the thyroid.
    Yalcin M; Dyskin E; Lansing L; Bharali DJ; Mousa SS; Bridoux A; Hercbergs AH; Lin HY; Davis FB; Glinsky GV; Glinskii A; Ma J; Davis PJ; Mousa SA
    J Clin Endocrinol Metab; 2010 Apr; 95(4):1972-80. PubMed ID: 20133461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.